Please login to the form below
15
Revenue 2017Novo Nordisk
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novo Nordisk's 2013 sales performance.
Novo Nordisk set to acquire Emisphere Technology for $1.8bn
Danish pharma will acquire all outstanding shares in Emisphere. Danish pharma company Novo Nordisk has announced an agreement to acquire drug delivery specialist Emisphere Technologies for $1.8bn. ... Mads Krogsgaard Thomsen, executive vice president and
NICE – but not enough
Around the same time (late 2018), Novo Nordisk launched Ozempic, also for type 2 diabetes, though a different class (GLP1).
On our best behaviour
Meanwhile, Novo Nordisk has launched Rybelsus (semaglutide) oral tablets to improve control of blood sugar – but specifically alongside diet and exercise.
Finalists
Diabetes Knowledge in Practice. by Liberum IME. With support from multiple supporters, including Novo Nordisk A/S and MSD.
Trust – years to build, seconds to break and forever to repair
We are also seeing some very unique partnerships, such as Novo Nordisk and Carlsberg working together to produce hand sanitiser for the Danish market.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
-
Medical Editor
-
Competitive
-
Healthcare Account Director
-
Competitive
- EU secures 405 million doses of CureVac’s COVID-19 vaccine
- Pfizer, Mylan move ahead with generics merger and spin-out
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- GSK chief exec ‘optimistic’ COVID-19 vaccine could be available next year
- FDA delays BMS’ liso-cel decision, citing COVID-19 travel restrictions
- Send Us a Message
- Laurence Bannister joins Lucid Group as its new Chief Commercial Officer
- AZ’s COVID-19 vaccine demonstrates efficacy rate of up to 90%
- UK could approve Pfizer’s COVID-19 vaccine this week
- Regeneron’s COVID-19 antibody cocktail scores FDA emergency approval
- Power to the patient: digital innovation supporting patients with chronic diseases
- New from the PhRMA: Diversity in clinical trials principles summarised
PMHub
Viseven
Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...
Latest intelligence
- New from the PhRMA: Diversity in clinical trials principles summarised
- In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
- New from the FDA: Diversity in clinical trials guidance summarised
- In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
- 5 steps to effective clinical trial branding
- When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...
Quick links
Infographics
